Dilaudid: Difference between revisions
CSV import |
CSV import Tag: Reverted |
||
| Line 60: | Line 60: | ||
[[Category:Analgesics]] | [[Category:Analgesics]] | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | |||
Revision as of 14:43, 10 February 2025
| Dilaudid | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | By mouth, intramuscular injection, intravenous injection, subcutaneous injection, rectal |
| Pregnancy category | |
| Bioavailability | Oral: 30–35%, Intranasal: 52–58% |
| Metabolism | Liver (primarily via glucuronidation) |
| Elimination half-life | 2–3 hours |
| Excretion | Kidney |
| Legal status | |
| CAS Number | 466-99-9 |
| PubChem | 5284570 |
| DrugBank | DB00327 |
| ChemSpider | |
| KEGG | D08047 |
Dilaudid is a potent opioid analgesic drug primarily used in the management of severe pain. The active ingredient in Dilaudid is hydromorphone, which is derived from morphine. It is commonly prescribed in hospitals and is available in various forms, including oral tablets, injectable solutions, and suppositories.
Medical Uses
Dilaudid is indicated for the relief of moderate to severe pain, such as that associated with surgery, cancer, or severe injuries. Due to its high potency, it is typically reserved for use when other pain management strategies are ineffective.
Pharmacology
Hydromorphone, the active component of Dilaudid, acts primarily on the mu-opioid receptor in the brain, spinal cord, and other tissues. This action produces analgesia, sedation, and a sense of well-being. However, like other opioids, it can also lead to respiratory depression, particularly at higher doses.
Side Effects
Common side effects of Dilaudid include dizziness, sedation, nausea, vomiting, constipation, and sweating. More severe risks involve respiratory depression, addiction, and overdose, particularly when used improperly or without medical supervision.
Addiction and Dependence
Hydromorphone is a Schedule II controlled substance in the United States due to its high potential for abuse and dependence. Patients using Dilaudid should be closely monitored for signs of addiction and abuse.
Formulations and Administration
Dilaudid is available in several formulations, including oral tablets, injectable solutions, and rectal suppositories. The route of administration depends on the clinical situation and patient needs.
Legal Status
As a controlled substance, Dilaudid is regulated under various national laws to prevent its misuse. In the United States, it is classified under Schedule II of the Controlled Substances Act.
